Clinical Trials · NCT07793019

IBI3042 Study in Healthy Participants and Overweight or Obese Participants

Not Yet RecruitingPhase 1Orforglipron (Investigational)
Phase
Phase 1
Recruitment status
Not Yet Recruiting
Sponsor
Innovent Biologics (Suzhou) Co. Ltd.
Enrollment
104
Start date
Sep 2026
Locations
1 site, China
Primary endpoint
Number of Participants With Adverse Events (Part A)
View Orforglipron compound reference